Merck makes a big move into new cancer treatments with a $6.7 billion
buyout deal
-
Merck to spend $6.7 billion to buy Terns Pharmaceuticals, which is
developing an oral treatment for leukemia.
31 minutes ago





CHANGE, ....ACCORDINGLY ; LOCATION and relocate is really WHERE are our priorities? Is there no room for attention to also be paid to innovations that have less promise regarding wealth, but serve broad and important social objectives? Have we completely lost our minds?
ReplyDelete